| Previous close | 186.64 |
| Open | 185.48 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's range | 184.00 - 186.82 |
| 52-week range | 133.64 - 191.10 |
| Volume | 2,275,630 |
| Avg. volume | 2,504,338 |
| Market cap | 135.54B |
| Beta | 1.79 |
| PE ratio (TTM) | 16.92 |
| EPS (TTM) | 10.98 |
| Earnings date | 25 Oct 2017 - 30 Oct 2017 |
| Dividend & yield | 4.60 (2.47%) |
| Ex-dividend date | 2017-08-15 |
| 1y target est | 187.25 |
- PR Newswire•2 days ago
Amgen Foundation Pledges Up To $5 Million To Hurricane Maria Relief Efforts
THOUSAND OAKS, Calif., Sept. 22, 2017 /PRNewswire/ -- Amgen (AMGN) today announced that the Amgen Foundation has pledged $3 million to support urgent Hurricane Maria relief efforts in Puerto Rico. The Foundation also has committed up to an additional $2 million for longer-term rebuilding efforts. Amgen is also activating its Staff Disaster Relief Fund to aid Amgen staff in Puerto Rico, including financial assistance for shelter, medical attention, clothing and other critical relief.
- Investopedia•3 days ago
Gilead, Amgen, and Biogen May Lift Biotech Higher
These drug juggernauts could bolster the entire biotechnology sector as we head toward year-end.
- Zacks•4 days ago
Pfizer Sues J&J, Accuses it of Preventing Inflectra Uptake
Pfizer (PFE) filed a lawsuit in a U.S. district court alleging that J&J is resorting to anticompetitive practices to prevent uptake of Inflectra.
